BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 17883112)

  • 1. Expression of cytokeratins in gliomas.
    Goswami C; Chatterjee U; Sen S; Chatterjee S; Sarkar S
    Indian J Pathol Microbiol; 2007 Jul; 50(3):478-81. PubMed ID: 17883112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of non-glial intermediate filament proteins in gliomas.
    Hirato J; Nakazato Y; Ogawa A
    Clin Neuropathol; 1994; 13(1):1-11. PubMed ID: 7518371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation of glial fibrillary acidic protein (GFAP) with grading of the neuroglial tumours.
    Reyaz N; Tayyab M; Khan SA; Siddique T
    J Coll Physicians Surg Pak; 2005 Aug; 15(8):472-5. PubMed ID: 16202357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Keratin intermediate filament expression in astrocytic neoplasms: analysis by immunocytochemistry, western blot, and northern hybridization.
    Cosgrove MM; Rich KA; Kunin SA; Sherrod AE; Martin SE
    Mod Pathol; 1993 May; 6(3):342-7. PubMed ID: 7688463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An immunocytochemical comparison of the glia-associated proteins glial fibrillary acidic protein (GFAP) and S-100 protein (S100P) in human brain tumors.
    Kimura T; Budka H; Soler-Federsppiel S
    Clin Neuropathol; 1986; 5(1):21-7. PubMed ID: 3512139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Co-expression of GFAP, vimentin and cytokeratins in GL-15 glioblastoma cell line.
    Perzelcová A; Máciková ; Tardy M; Mráz P; Steno J; Bízik I
    Neoplasma; 2000; 47(6):362-6. PubMed ID: 11263860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytokeratin 7 and cytokeratin 20 expression in epithelial neoplasms: a survey of 435 cases.
    Chu P; Wu E; Weiss LM
    Mod Pathol; 2000 Sep; 13(9):962-72. PubMed ID: 11007036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytokeratin 7 and 20 expression in choroid plexus tumors: utility in differentiating these neoplasms from metastatic carcinomas.
    Gyure KA; Morrison AL
    Mod Pathol; 2000 Jun; 13(6):638-43. PubMed ID: 10874668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systematic immunohistochemical profiling of 378 brain tumors with 37 antibodies using tissue microarray technology.
    Ikota H; Kinjo S; Yokoo H; Nakazato Y
    Acta Neuropathol; 2006 May; 111(5):475-82. PubMed ID: 16598485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced glial fibrillary acidic protein-delta expression in human astrocytic tumor.
    Choi KC; Kwak SE; Kim JE; Sheen SH; Kang TC
    Neurosci Lett; 2009 Oct; 463(3):182-7. PubMed ID: 19647039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinicopathological study on malignant glioma--with special reference to GFAP].
    Tajika T; Kubo O; Tajika Y; Toyama T; Himuro H; Inoue N; Sakairi M; Kitamura K
    No Shinkei Geka; 1986 Jun; 14(7):831-5. PubMed ID: 3020463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Differential immunohistochemical diagnosis of tumors of the human central nervous system using monoclonal antibodies].
    Vial'tseva IuIu; Bukhvalov IB; Vasilov RG
    Arkh Patol; 1996; 58(2):28-32. PubMed ID: 8712936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nestin expression in astrocytic tumors delineates tumor infiltration.
    Kitai R; Horita R; Sato K; Yoshida K; Arishima H; Higashino Y; Hashimoto N; Takeuchi H; Kubota T; Kikuta K
    Brain Tumor Pathol; 2010 Apr; 27(1):17-21. PubMed ID: 20425043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glial fibrillary acidic protein expression in pleomorphic adenoma, chordoma, and astrocytoma. A comparison of three antibodies.
    Wittchow R; Landas SK
    Arch Pathol Lab Med; 1991 Oct; 115(10):1030-3. PubMed ID: 1654872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HEA 125 and Ber EP4: two monoclonal anti-epithelial, non-cytokeratin antibodies distinguishing metastatic carcinomas from glial tumors.
    Gottschalk J; Jautzke G; Zimmer C; Cervós-Navarro J
    Clin Neuropathol; 1993; 12(2):68-72. PubMed ID: 7682900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patterns of expression of TSC-22 protein in astrocytic gliomas.
    Shostak KO; Dmitrenko VV; Vudmaska MI; Naidenov VG; Beletskii AV; Malisheva TA; Semenova VM; Zozulya YP; Demotes-Mainard J; Kavsan VM
    Exp Oncol; 2005 Dec; 27(4):314-8. PubMed ID: 16404353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of monoclonal antibodies to glial fibrillary acidic protein in the cytologic diagnosis of brain tumors.
    Chen Y; Zhang YX
    Acta Cytol; 1989; 33(6):922-8. PubMed ID: 2588925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD44 expression in astrocytic tumors.
    Ylagan LR; Quinn B
    Mod Pathol; 1997 Dec; 10(12):1239-46. PubMed ID: 9436970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gliosarcoma: a histologic and immunohistochemical reaffirmation.
    Meis JM; Ho KL; Nelson JS
    Mod Pathol; 1990 Jan; 3(1):19-24. PubMed ID: 2155418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The contribution of immunohistochemistry to the differential diagnosis of primary and metastatic neoplasma of the central nervous system (CNS).
    Markaki S; Prevedorou D; Georgoulakis G; Bouja J; Karabela-Bouropoulou V
    Arch Anat Cytol Pathol; 1989; 37(3):93-8. PubMed ID: 2751365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.